Article Information
History
- March 28, 2022.
Article Versions
- Version 1 (June 27, 2021 - 13:30).
- You are viewing Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Mariann Koel1,*,
- Urmo Võsa1,*,
- Maarja Lepamets1,
- Kristi Läll1,
- Natàlia Pujol-Gualdo1,
- Hannele Laivuori2,3,4,
- Susanna Lemmelä2,
- Mark Daly2,
- Estonian Biobank Research Team,
- FinnGen,
- Priit Palta1,2,
- Reedik Mägi1 and
- Triin Laisk1,#
- 1Estonian Genome Centre, Institute of Genomics, University of Tartu, Tartu, Estonia
- 2Institute for Molecular Medicine Finland, FIMM, HiLIFE, University of Helsinki, Helsinki, Finland
- 3Department of Obstetrics and Gynecology, Tampere University Hospital and Tampere University, Faculty of Medicine and Health Technology, Tampere, Finland
- 4Medical and Clinical Genetics, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- ↵#Corresponding author: T. Laisk, triin.laisk{at}ut.ee
↵* These authors contributed equally
Posted March 28, 2022.
GWAS meta-analysis and gene expression data link reproductive tract development, immune response and cellular proliferation/apoptosis with cervical cancer and clarify overlap with other cervical phenotypes
